Chronic Inflammatory Demyelinating Polyneuropathy: Clinical Trials

3 trials for Chronic Inflammatory Demyelinating Polyneuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Chronic Inflammatory Demyelinating Polyneuropathy: new trials by email Literature Review of Chronic Inflammatory Demyelinating Polyneuropathy trials Research Report on Chronic Inflammatory Demyelinating Polyneuropathy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study
MD1003 - Chronic Inflammatory Demyelinating Polyneuropathy, Peripheral Neuropathy
Phase 2CompletedMedDay Pharmaceuticals SA152016-12-052020-11-02
Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy
lipoic acid - CIDP, Chronic Inflammatory Demyelinating Polyneuropathy
Phase 2CompletedOregon Health and Science University72009-02-012020-08-19
Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy
hematopoietic stem cell transplantation - Chronic Inflammatory Demyelinating Polyneuropathy
Phase 2CompletedNorthwestern University802005-02-212020-07-23

Narrower conditions

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (3)  ·  Charcot-Marie-Tooth Disease (1)  ·  Peripheral Nervous System Diseases (1)

Broader conditions

Autoimmune Diseases (3)  ·  Autoimmune Diseases of the Nervous System (3)  ·  Chronic Disease (3)  ·  Demyelinating Diseases (3)  ·  Disease Attributes (3)  ·  Immune System Diseases (3)  ·  Nervous System Diseases (3)  ·  Neuromuscular Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Polyneuropathies (3)  ·  Polyradiculoneuropathy (3)  ·  Peripheral Nervous System Diseases (2)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Biotin (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Thioctic Acid (1)

Sponsors

MedDay Pharmaceuticals SA (1)  ·  Northwestern University (1)  ·  Oregon Health and Science University (1)

Countries

United States (2)  ·  France (1)

Top investigators

Frederic Sedel, MD (1)  ·  Jau-Shin Lou, MD, PhD (1)  ·  Richard Burt, MD (1)

Results publications

PMID 32594300, PMID 37899433